Clinical Trials Browser

Phase 1/2 × Ovarian Cancer Recurrent × pembrolizumab × Clear all

NCT06843447 2026-05-26

MK-5909-003

Phase 1/2 Recruiting

Ovarian Cancer Recurrent

NCT03734692 2026-02-12

Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer

Phase 1/2 Active not recruiting

24 enrolled 59 charts

Ovarian Cancer Recurrent